187 related articles for article (PubMed ID: 32382873)
1. Covid-19 and drug therapy, what we learned.
Provenzani A; Polidori P
Int J Clin Pharm; 2020 Jun; 42(3):833-836. PubMed ID: 32382873
[TBL] [Abstract][Full Text] [Related]
2. Of chloroquine and COVID-19.
Touret F; de Lamballerie X
Antiviral Res; 2020 May; 177():104762. PubMed ID: 32147496
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 and COVID-19: What are our options? Where should we focus our attention on to find new drugs and strategies?
Magro G
Travel Med Infect Dis; 2020; 37():101685. PubMed ID: 32334088
[No Abstract] [Full Text] [Related]
4. Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research.
Bimonte S; Crispo A; Amore A; Celentano E; Cuomo A; Cascella M
In Vivo; 2020 Jun; 34(3 Suppl):1597-1602. PubMed ID: 32503817
[TBL] [Abstract][Full Text] [Related]
5. Drug treatment of coronavirus disease 2019 (COVID-19) in China.
Jin Z; Liu JY; Feng R; Ji L; Jin ZL; Li HB
Eur J Pharmacol; 2020 Sep; 883():173326. PubMed ID: 32598953
[TBL] [Abstract][Full Text] [Related]
6. Drug Discovery Strategies for SARS-CoV-2.
Shyr ZA; Gorshkov K; Chen CZ; Zheng W
J Pharmacol Exp Ther; 2020 Oct; 375(1):127-138. PubMed ID: 32723801
[TBL] [Abstract][Full Text] [Related]
7. News Feature: To counter the pandemic, clinicians bank on repurposed drugs.
Madhusoodanan J
Proc Natl Acad Sci U S A; 2020 May; 117(20):10616-10620. PubMed ID: 32350142
[No Abstract] [Full Text] [Related]
8. Metabolomics to Predict Antiviral Drug Efficacy in COVID-19.
Migaud M; Gandotra S; Chand HS; Gillespie MN; Thannickal VJ; Langley RJ
Am J Respir Cell Mol Biol; 2020 Sep; 63(3):396-398. PubMed ID: 32574504
[No Abstract] [Full Text] [Related]
9. Repurposing old drugs as antiviral agents for coronaviruses.
Yang CW; Peng TT; Hsu HY; Lee YZ; Wu SH; Lin WH; Ke YY; Hsu TA; Yeh TK; Huang WZ; Lin JH; Sytwu HK; Chen CT; Lee SJ
Biomed J; 2020 Aug; 43(4):368-374. PubMed ID: 32563698
[TBL] [Abstract][Full Text] [Related]
10. Coronavirus disease 2019 (COVID-19): first indication of efficacy of Gene-Eden-VIR/Novirin in SARS-CoV-2 infection.
Polansky H; Lori G
Int J Antimicrob Agents; 2020 Jun; 55(6):105971. PubMed ID: 32283177
[No Abstract] [Full Text] [Related]
11. Overview of therapeutic drug research for COVID-19 in China.
Li H; Yang L; Liu FF; Ma XN; He PL; Tang W; Tong XK; Zuo JP
Acta Pharmacol Sin; 2020 Sep; 41(9):1133-1140. PubMed ID: 32555446
[TBL] [Abstract][Full Text] [Related]
12. Drug Repurposing Study Pinpoints Potential COVID-19 Antivirals.
Abbasi J
JAMA; 2020 Sep; 324(10):928. PubMed ID: 32897326
[No Abstract] [Full Text] [Related]
13. SARS-CoV-2 RNA polymerase as target for antiviral therapy.
Buonaguro L; Tagliamonte M; Tornesello ML; Buonaguro FM
J Transl Med; 2020 May; 18(1):185. PubMed ID: 32370758
[TBL] [Abstract][Full Text] [Related]
14. Microbicidal actives with virucidal efficacy against SARS-CoV-2.
Ijaz MK; Whitehead K; Srinivasan V; McKinney J; Rubino JR; Ripley M; Jones C; Nims RW; Charlesworth B
Am J Infect Control; 2020 Aug; 48(8):972-973. PubMed ID: 32461067
[No Abstract] [Full Text] [Related]
15. SARS-CoV-2 and HIV: Epidemiology, Treatment, and Lessons Learned from HIV.
Castel AD; Wilbourn B; Magnus M; Greenberg AE
AIDS Rev; 2020; 22(3):133-142. PubMed ID: 33118529
[TBL] [Abstract][Full Text] [Related]
16. The Landscape of Prescription Drug Shortages During the COVID-19 Pandemic.
Fox ER; Stolbach AI; Mazer-Amirshahi M
J Med Toxicol; 2020 Jul; 16(3):311-313. PubMed ID: 32458230
[No Abstract] [Full Text] [Related]
17. Fighting the Coronavirus Outbreak.
Kiessling L; Chen P; Wang J; Li JP
ACS Chem Biol; 2020 Apr; 15(4):799-801. PubMed ID: 32233418
[No Abstract] [Full Text] [Related]
18. COVID-19 and toxicity from potential treatments: Panacea or poison.
Wong A
Emerg Med Australas; 2020 Aug; 32(4):697-699. PubMed ID: 32378805
[TBL] [Abstract][Full Text] [Related]
19. Optimization Rules for SARS-CoV-2 M
Stoddard SV; Stoddard SD; Oelkers BK; Fitts K; Whalum K; Whalum K; Hemphill AD; Manikonda J; Martinez LM; Riley EG; Roof CM; Sarwar N; Thomas DM; Ulmer E; Wallace FE; Pandey P; Roy S
Viruses; 2020 Aug; 12(9):. PubMed ID: 32859008
[TBL] [Abstract][Full Text] [Related]
20. COVID-19: A Defining Moment for Clinical Pharmacology?
van der Graaf PH; Giacomini KM
Clin Pharmacol Ther; 2020 Jul; 108(1):11-15. PubMed ID: 32350861
[No Abstract] [Full Text] [Related]
[Next] [New Search]
